Last updated: November 27, 2025
Sponsor: Ester Ashraf Faried Beshay
Overall Status: Active - Recruiting
Phase
N/A
Condition
Cardiovascular Disease
Deep Vein Thrombosis
Thrombosis
Treatment
N/AClinical Study ID
NCT06081881
CTEPH after pulmonary embolism
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Any patient diagnosed as acute pulmonary embolism ,aged between 18-80 years old which Pulmonary Embolism Severity Index (PESI) class III-V or sPESI ≥1,
Exclusion
Exclusion Criteria:
Secondary causes for pulmonary hypertension Severe kidney injury(eGFR>30 mg/dl/1.7m2) Hepatic affection Contraindication to anti-coagulation
Study Design
Total Participants: 100
Study Start date:
January 01, 2025
Estimated Completion Date:
December 01, 2026
Study Description
Connect with a study center
Assiut University
Asyut 359783, AssiutU
EgyptActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.